| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |